PL2173710T3 - Nowa postać krystaliczna - Google Patents

Nowa postać krystaliczna

Info

Publication number
PL2173710T3
PL2173710T3 PL08788654T PL08788654T PL2173710T3 PL 2173710 T3 PL2173710 T3 PL 2173710T3 PL 08788654 T PL08788654 T PL 08788654T PL 08788654 T PL08788654 T PL 08788654T PL 2173710 T3 PL2173710 T3 PL 2173710T3
Authority
PL
Poland
Prior art keywords
crystalline form
novel crystalline
novel
crystalline
Prior art date
Application number
PL08788654T
Other languages
English (en)
Inventor
Axel Becker
Original Assignee
Generics Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38543380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2173710(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Generics Uk Ltd filed Critical Generics Uk Ltd
Publication of PL2173710T3 publication Critical patent/PL2173710T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal Substances (AREA)
PL08788654T 2007-08-10 2008-08-08 Nowa postać krystaliczna PL2173710T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0715626.8A GB0715626D0 (en) 2007-08-10 2007-08-10 Crystalline form of zofenopril calcium
EP08788654.5A EP2173710B1 (en) 2007-08-10 2008-08-08 Novel crystalline form
PCT/GB2008/050683 WO2009022168A1 (en) 2007-08-10 2008-08-08 Novel crystalline form

Publications (1)

Publication Number Publication Date
PL2173710T3 true PL2173710T3 (pl) 2016-02-29

Family

ID=38543380

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08788654T PL2173710T3 (pl) 2007-08-10 2008-08-08 Nowa postać krystaliczna

Country Status (14)

Country Link
US (1) US8710241B2 (pl)
EP (1) EP2173710B1 (pl)
JP (1) JP5455905B2 (pl)
CN (1) CN101815702B (pl)
AU (1) AU2008288295B2 (pl)
CA (1) CA2694835C (pl)
DK (1) DK2173710T3 (pl)
ES (1) ES2556227T3 (pl)
GB (1) GB0715626D0 (pl)
HR (1) HRP20151166T1 (pl)
HU (1) HUE028205T2 (pl)
PL (1) PL2173710T3 (pl)
PT (1) PT2173710E (pl)
WO (1) WO2009022168A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8853421B2 (en) 2008-02-27 2014-10-07 Generics [Uk] Limited Crystalline forms of zofenopril calcium
JP5530369B2 (ja) * 2008-02-27 2014-06-25 ジェネリクス・［ユーケー］・リミテッド 新規な結晶形
SI23949A (sl) 2011-12-19 2013-06-28 Silverstone Pharma Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji
CN104138359B (zh) * 2013-05-06 2016-03-02 扬子江药业集团上海海尼药业有限公司 佐芬普利钙片的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
US4316906A (en) * 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
IT1301993B1 (it) * 1998-08-04 2000-07-20 Menarini Ricerche Spa Processo per la preparazione di zofenopril sale di calcio.
US20050209288A1 (en) * 2004-01-12 2005-09-22 Grogan Donna R Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use
CA2614193C (en) * 2005-07-01 2014-01-28 Generics [Uk] Limited Zofenopril calcium in polymorph form c
PL2041083T3 (pl) 2006-05-26 2015-04-30 Generics Uk Ltd Sposoby otrzymywania zofenoprylu wapnia
CN101012192A (zh) * 2007-01-30 2007-08-08 广东邦民制药厂有限公司 一种佐芬普利钙的制备方法

Also Published As

Publication number Publication date
CN101815702A (zh) 2010-08-25
DK2173710T3 (en) 2015-11-23
EP2173710B1 (en) 2015-09-16
AU2008288295B2 (en) 2013-06-06
WO2009022168A1 (en) 2009-02-19
HRP20151166T1 (hr) 2016-01-01
PT2173710E (pt) 2016-01-12
ES2556227T3 (es) 2016-01-14
CN101815702B (zh) 2012-10-24
CA2694835A1 (en) 2009-02-19
JP5455905B2 (ja) 2014-03-26
US20110098334A1 (en) 2011-04-28
HUE028205T2 (en) 2016-12-28
US8710241B2 (en) 2014-04-29
GB0715626D0 (en) 2007-09-19
JP2010535753A (ja) 2010-11-25
AU2008288295A1 (en) 2009-02-19
CA2694835C (en) 2013-01-29
EP2173710A1 (en) 2010-04-14

Similar Documents

Publication Publication Date Title
GB0819182D0 (en) Crystalline forms
EP2152081A4 (en) NEW CONNECTIONS
EP2146745A4 (en) NOVEL CONNECTIONS
GB0705882D0 (en) Novel compounds
GB0706630D0 (en) Novel compounds
GB0705803D0 (en) Novel compounds
PL2173710T3 (pl) Nowa postać krystaliczna
ZA200806859B (en) Novel crystalline compounds
GB0706772D0 (en) Novel compound
GB0703973D0 (en) Novel compounds
IL195092A0 (en) Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
HU0800755D0 (en) Novel crystalline forms
GB0817164D0 (en) Crystalline forms
IL213288A0 (en) Crystalline forms
GB0717333D0 (en) Novel compound
GB0717338D0 (en) Novel compound
GB0717468D0 (en) Novel compound
GB0720917D0 (en) Novel compound
GB0717336D0 (en) Novel compound
GB0717335D0 (en) Novel compound
GB0717334D0 (en) Novel compound
GB0717332D0 (en) Novel compound
GB0710864D0 (en) Novel compound
GB0700991D0 (en) Novel compounds
GB0704088D0 (en) Novel compounds